CD274 and neoplasm: Small molecule inhibitors of PDL1 and PD1 are also described [28,29], but these were generally designed to replace the antibody action of inhibiting PDL1/PD1 interactions at cell surfaces and not to reduce tumor-intrinsic PDL1.